High Prevalence of Potential Drug-Drug Interactions for Psoriasis Patients Prescribed Methotrexate or Cyclosporine for Psoriasis: Associated Clinical and Economic Outcomes in Real-World PracticeSAURAT, Jean-Hilaire; GUERIN, Annie; YU, Andrew P et al.Dermatology (Basel). 2010, Vol 220, Num 2, pp 128-137, issn 1018-8665, 10 p.Article

Increased Risks of Developing Anxiety and Depression in Young Patients With Crohn's DiseaseLOFTUS, Edward V; GUERIN, Annie; YU, Andrew P et al.The American journal of gastroenterology. 2011, Vol 106, Num 9, pp 1670-1677, issn 0002-9270, 8 p.Article

Coronary Heart Disease and Stroke Risk in Patients with Psoriasis: Retrospective AnalysisBOER KIMBALL, Alexa; GUERIN, Annie; LATREMOUILLE-VIAU, Dominick et al.The American journal of medicine. 2010, Vol 123, Num 4, pp 350-357, issn 0002-9343, 8 p.Article

Risks of developing psychiatric disorders in pediatric patients with psoriasisKIMBALL, Alexa B; WU, Eric Q; GUERIN, Annie et al.Journal of the American Academy of Dermatology. 2012, Vol 67, Num 4, pp 651-657, issn 0190-9622, 7 p.Article

Consequences of aggregation for the trace element distribution in the subsoil of a Planosol naturally rich in trace metalCOMU, Sophie; COUSIN, Isabelle; DESCHATRETTES, Valérie et al.Geoderma (Amsterdam). 2006, Vol 136, Num 1-2, pp 160-173, issn 0016-7061, 14 p.Article

Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab-carboplatin-paclitaxel and carboplatin-paclitaxel: A retrospective cohort studyLANGER, Corey; RAVELO, Arliene; HAZARD, Sebastien J et al.Lung cancer. 2014, Vol 86, Num 3, pp 350-357, issn 0169-5002, 8 p.Article

Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health DataMEASE, Philip J; ZIMETBAUM, Peter J; MEI SHENG DUH et al.The Annals of pharmacotherapy. 2011, Vol 45, Num 2, pp 179-188, issn 1060-0280, 10 p.Article

Comparing nilotinib with dasatinib as second-line therapies in patients with chronic myelogenous leukemia resistant or intolerant to imatinib ― a retrospective chart review analysisGRIFFIN, James D; GUERIN, Annie; LEI CHEN et al.Current medical research and opinion. 2013, Vol 29, Num 6, pp 623-631, issn 0300-7995, 9 p.Article

Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities: Subanalysis of Results from a Randomized, Double-Blind, Placebo-Controlled, Phase III TrialKIMBALL, Alexa B; BENSIMON, Arielle G; GUERIN, Annie et al.American journal of clinical dermatology. 2011, Vol 12, Num 1, pp 51-62, issn 1175-0561, 12 p.Article

Clinical and economic outcomes of multiple versus single long-acting inhalers in COPDYU, Andrew P; GUERIN, Annie; PONCE DE LEON, Diego et al.Respiratory medicine. 2011, Vol 105, Num 12, pp 1861-1871, issn 0954-6111, 11 p.Article

Association between regular molecular monitoring and tyrosine kinase inhibitor therapy adherence in chronic myelogenous leukemia in the chronic phaseGUERIN, Annie; LEI CHEN; DEA, Katherine et al.Current medical research and opinion. 2014, Vol 30, Num 7, pp 1345-1352, issn 0300-7995, 8 p.Article

Association between molecular monitoring and long-term outcomes in chronic myelogenous leukemia patients treated with first line imatinibGOLDBERG, Stuart L; LEI CHEN; GUERIN, Annie et al.Current medical research and opinion. 2013, Vol 29, Num 9, pp 1075-1082, issn 0300-7995, 8 p.Article

Impact of nonadherence to antiepileptic drugs on health care utilization and costs : Findings from the RANSOM studyFAUGHT, R. Edward; WEINER, Jennifer R; GUERIN, Annie et al.Epilepsia (Copenhagen). 2009, Vol 50, Num 3, pp 501-509, issn 0013-9580, 9 p.Article

Outcomes in atrial fibrillation patients on combined warfarin & antiarrhythmic therapyGUÉRIN, Annie; LIN, Jay; JHAVERI, Mehul et al.International journal of cardiology. 2013, Vol 167, Num 2, pp 564-569, issn 0167-5273, 6 p.Article